医学
腹膜透析
重症监护医学
指南
疾病
心房颤动
工作组
心源性猝死
冠状动脉疾病
肾脏疾病
透析
风险评估
内科学
心脏病学
病理
计算机科学
计算机安全
计算机网络
作者
Angela Yee‐Moon Wang,K. Scott Brimble,Gillian Brunier,S. Holt,Vivekanand Jha,David W. Johnson,Shin‐Wook Kang,Jeroen P. Kooman,Mark Lambie,Chris McIntyre,Rajnish Mehrotra,Roberto Pecoits–Filho
标识
DOI:10.3747/pdi.2014.00279
摘要
Cardiovascular disease contributes significantly to the adverse clinical outcomes of peritoneal dialysis (PD) patients. Numerous cardiovascular risk factors play important roles in the development of various cardiovascular complications. Of these, loss of residual renal function is regarded as one of the key cardiovascular risk factors and is associated with an increased mortality and cardiovascular death. It is also recognized that PD solutions may incur significant adverse metabolic effects in PD patients. The International Society for Peritoneal Dialysis (ISPD) commissioned a global workgroup in 2012 to formulate a series of recommendations regarding lifestyle modification, assessment and management of various cardiovascular risk factors, as well as management of the various cardiovascular complications including coronary artery disease, heart failure, arrhythmia (specifically atrial fibrillation), cerebrovascular disease, peripheral arterial disease and sudden cardiac death, to be published in 2 guideline documents. This publication forms the first part of the guideline documents and includes recommendations on assessment and management of various cardiovascular risk factors. The documents are intended to serve as a global clinical practice guideline for clinicians who look after PD patients. The ISPD workgroup also identifies areas where evidence is lacking and further research is needed.
科研通智能强力驱动
Strongly Powered by AbleSci AI